HEADER TRANSFERASE 08-MAR-18 6CNH TITLE HUMAN PRPF4B IN COMPLEX WITH REBASTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PRP4 HOMOLOG; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 657-1005; COMPND 5 SYNONYM: PRPF4B, PRP4 KINASE, PRP4 PRE-MRNA-PROCESSING FACTOR 4 COMPND 6 HOMOLOG; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, INHIBITOR, DCC2036, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.H.C.GODOI,A.S.SANTIAGO,P.Z.RAMOS,A.M.FALA,A.P.T.SALMAZO, AUTHOR 2 R.M.COUNAGO,G.L.RIGHETTO,P.N.B.SILVA,O.GILEADI,C.R.W.GUIMARAES, AUTHOR 3 K.B.MASSIRER,P.ARRUDA,J.M.ELKINS,A.M.EDWARDS,STRUCTURAL GENOMICS AUTHOR 4 CONSORTIUM (SGC) REVDAT 4 04-OCT-23 6CNH 1 REMARK REVDAT 3 01-JAN-20 6CNH 1 REMARK REVDAT 2 17-APR-19 6CNH 1 REMARK REVDAT 1 28-MAR-18 6CNH 0 JRNL AUTH P.H.C.GODOI,A.S.SANTIAGO,P.Z.RAMOS,P.N.B.SILVA,G.L.RIGHETTO, JRNL AUTH 2 C.R.W.GUIMARAES,K.B.MASSIRER,P.ARRUDA,J.M.ELKINS,A.M.EDWARDS JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN PRPF4B IN COMPLEX WITH JRNL TITL 2 REBASTINIB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 27710 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1351 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2048 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.44 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE SET COUNT : 84 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2580 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 147 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.01000 REMARK 3 B22 (A**2) : 1.24000 REMARK 3 B33 (A**2) : -0.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.60000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.153 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.134 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.102 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.735 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2721 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2554 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3677 ; 1.270 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5906 ; 0.924 ; 2.987 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 326 ; 5.582 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 125 ;34.262 ;24.160 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 499 ;14.253 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;16.948 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 406 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2969 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 553 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1293 ; 2.001 ; 3.949 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1292 ; 1.999 ; 3.948 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1612 ; 2.994 ; 5.901 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1613 ; 2.993 ; 5.902 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1428 ; 2.533 ; 4.319 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1413 ; 2.525 ; 4.301 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2038 ; 4.114 ; 6.324 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3086 ; 5.979 ;46.134 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3051 ; 5.918 ;45.832 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6CNH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000233091. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.968610 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29242 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 67.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.53500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.17 REMARK 200 STARTING MODEL: PDB ENTRY 4IJP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG SMEAR HIGH, 0.1 M N-(2 REMARK 280 -ACETAMIDO)IMINODIACETIC ACID, 0.2 M AMMONIUM SULFATE, PH 6.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 42.58450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.83050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 42.58450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.83050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1346 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 659 REMARK 465 GLU A 660 REMARK 465 ASN A 661 REMARK 465 PRO A 662 REMARK 465 ASN A 663 REMARK 465 LEU A 664 REMARK 465 ARG A 665 REMARK 465 ASP A 666 REMARK 465 ASN A 667 REMARK 465 GLY A 836 REMARK 465 SER A 837 REMARK 465 ALA A 838 REMARK 465 SER A 839 REMARK 465 HIS A 840 REMARK 465 VAL A 841 REMARK 465 ALA A 842 REMARK 465 ASP A 843 REMARK 465 ASN A 844 REMARK 465 ASP A 845 REMARK 465 ILE A 846 REMARK 465 THR A 847 REMARK 465 PRO A 848 REMARK 465 TYR A 849 REMARK 465 VAL A 934 REMARK 465 ASP A 935 REMARK 465 LYS A 936 REMARK 465 VAL A 937 REMARK 465 THR A 938 REMARK 465 GLU A 939 REMARK 465 ARG A 940 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 676 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 723 CG CD OE1 OE2 REMARK 470 LYS A 727 CG CD CE NZ REMARK 470 LYS A 731 CD CE NZ REMARK 470 GLU A 734 CD OE1 OE2 REMARK 470 LYS A 737 CE NZ REMARK 470 LYS A 747 CD CE NZ REMARK 470 LYS A 790 CD CE NZ REMARK 470 LYS A 827 NZ REMARK 470 LEU A 850 CG CD1 CD2 REMARK 470 LYS A 892 CG CD CE NZ REMARK 470 GLN A 925 CG CD OE1 NE2 REMARK 470 ARG A 964 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 967 CG CD OE1 OE2 REMARK 470 GLU A1005 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 686 -34.06 -156.63 REMARK 500 VAL A 697 -60.33 -94.31 REMARK 500 ARG A 755 -177.61 -173.07 REMARK 500 ASP A 815 43.09 -149.65 REMARK 500 ASP A 867 -157.63 -148.50 REMARK 500 LEU A 984 31.19 -90.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 919 A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1105 DBREF 6CNH A 657 1005 UNP Q13523 PRP4B_HUMAN 657 1005 SEQADV 6CNH SER A 655 UNP Q13523 EXPRESSION TAG SEQADV 6CNH MET A 656 UNP Q13523 EXPRESSION TAG SEQADV 6CNH LEU A 754 UNP Q13523 PHE 754 CONFLICT SEQADV 6CNH PHE A 851 UNP Q13523 VAL 851 CONFLICT SEQRES 1 A 351 SER MET ASP PHE LYS GLU ASN PRO ASN LEU ARG ASP ASN SEQRES 2 A 351 TRP THR ASP ALA GLU GLY TYR TYR ARG VAL ASN ILE GLY SEQRES 3 A 351 GLU VAL LEU ASP LYS ARG TYR ASN VAL TYR GLY TYR THR SEQRES 4 A 351 GLY GLN GLY VAL PHE SER ASN VAL VAL ARG ALA ARG ASP SEQRES 5 A 351 ASN ALA ARG ALA ASN GLN GLU VAL ALA VAL LYS ILE ILE SEQRES 6 A 351 ARG ASN ASN GLU LEU MET GLN LYS THR GLY LEU LYS GLU SEQRES 7 A 351 LEU GLU PHE LEU LYS LYS LEU ASN ASP ALA ASP PRO ASP SEQRES 8 A 351 ASP LYS PHE HIS CYS LEU ARG LEU LEU ARG HIS PHE TYR SEQRES 9 A 351 HIS LYS GLN HIS LEU CYS LEU VAL PHE GLU PRO LEU SER SEQRES 10 A 351 MET ASN LEU ARG GLU VAL LEU LYS LYS TYR GLY LYS ASP SEQRES 11 A 351 VAL GLY LEU HIS ILE LYS ALA VAL ARG SER TYR SER GLN SEQRES 12 A 351 GLN LEU PHE LEU ALA LEU LYS LEU LEU LYS ARG CYS ASN SEQRES 13 A 351 ILE LEU HIS ALA ASP ILE LYS PRO ASP ASN ILE LEU VAL SEQRES 14 A 351 ASN GLU SER LYS THR ILE LEU LYS LEU CYS ASP PHE GLY SEQRES 15 A 351 SER ALA SER HIS VAL ALA ASP ASN ASP ILE THR PRO TYR SEQRES 16 A 351 LEU PHE SER ARG PHE TYR ARG ALA PRO GLU ILE ILE ILE SEQRES 17 A 351 GLY LYS SER TYR ASP TYR GLY ILE ASP MET TRP SER VAL SEQRES 18 A 351 GLY CYS THR LEU TYR GLU LEU TYR THR GLY LYS ILE LEU SEQRES 19 A 351 PHE PRO GLY LYS THR ASN ASN HIS MET LEU LYS LEU ALA SEQRES 20 A 351 MET ASP LEU LYS GLY LYS MET PRO ASN LYS MET ILE ARG SEQRES 21 A 351 LYS GLY VAL PHE LYS ASP GLN HIS PHE ASP GLN ASN LEU SEQRES 22 A 351 ASN PHE MET TYR ILE GLU VAL ASP LYS VAL THR GLU ARG SEQRES 23 A 351 GLU LYS VAL THR VAL MET SER THR ILE ASN PRO THR LYS SEQRES 24 A 351 ASP LEU LEU ALA ASP LEU ILE GLY CYS GLN ARG LEU PRO SEQRES 25 A 351 GLU ASP GLN ARG LYS LYS VAL HIS GLN LEU LYS ASP LEU SEQRES 26 A 351 LEU ASP GLN ILE LEU MET LEU ASP PRO ALA LYS ARG ILE SEQRES 27 A 351 SER ILE ASN GLN ALA LEU GLN HIS ALA PHE ILE GLN GLU HET 919 A1101 41 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET SO4 A1105 5 HETNAM 919 4-[4-({[3-TERT-BUTYL-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5- HETNAM 2 919 YL]CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE- HETNAM 3 919 2-CARBOXAMIDE HETNAM SO4 SULFATE ION HETSYN 919 DCC-2036 FORMUL 2 919 C30 H28 F N7 O3 FORMUL 3 SO4 4(O4 S 2-) FORMUL 7 HOH *147(H2 O) HELIX 1 AA1 ASN A 722 ASP A 743 1 22 HELIX 2 AA2 LEU A 774 GLY A 782 1 9 HELIX 3 AA3 HIS A 788 CYS A 809 1 22 HELIX 4 AA4 LYS A 817 ASP A 819 5 3 HELIX 5 AA5 LEU A 850 ARG A 856 5 7 HELIX 6 AA6 ALA A 857 GLY A 863 1 7 HELIX 7 AA7 TYR A 868 GLY A 885 1 18 HELIX 8 AA8 THR A 893 GLY A 906 1 14 HELIX 9 AA9 PRO A 909 LYS A 915 1 7 HELIX 10 AB1 PHE A 918 PHE A 923 1 6 HELIX 11 AB2 ASP A 954 GLY A 961 1 8 HELIX 12 AB3 PRO A 966 LEU A 984 1 19 HELIX 13 AB4 ASP A 987 ARG A 991 5 5 HELIX 14 AB5 SER A 993 GLN A 999 1 7 HELIX 15 AB6 HIS A 1000 GLU A 1005 1 6 SHEET 1 AA1 2 MET A 656 ASP A 657 0 SHEET 2 AA1 2 ILE A 811 LEU A 812 -1 O LEU A 812 N MET A 656 SHEET 1 AA2 6 VAL A 682 LEU A 683 0 SHEET 2 AA2 6 TYR A 687 TYR A 692 -1 O TYR A 687 N LEU A 683 SHEET 3 AA2 6 ASN A 700 ASP A 706 -1 O ARG A 703 N GLY A 691 SHEET 4 AA2 6 GLU A 713 ILE A 718 -1 O ILE A 718 N ASN A 700 SHEET 5 AA2 6 HIS A 762 PHE A 767 -1 O PHE A 767 N ALA A 715 SHEET 6 AA2 6 LEU A 753 HIS A 759 -1 N LEU A 754 O VAL A 766 SHEET 1 AA3 3 MET A 772 ASN A 773 0 SHEET 2 AA3 3 ILE A 821 VAL A 823 -1 O VAL A 823 N MET A 772 SHEET 3 AA3 3 LEU A 830 LEU A 832 -1 O LYS A 831 N LEU A 822 SHEET 1 AA4 2 PHE A 929 ILE A 932 0 SHEET 2 AA4 2 VAL A 943 MET A 946 -1 O THR A 944 N TYR A 931 SITE 1 AC1 18 SER A 655 THR A 693 GLN A 695 VAL A 701 SITE 2 AC1 18 ALA A 715 LYS A 717 THR A 728 LYS A 731 SITE 3 AC1 18 GLU A 732 LEU A 739 LEU A 751 PHE A 767 SITE 4 AC1 18 GLU A 768 LEU A 770 HIS A 813 CYS A 833 SITE 5 AC1 18 ASP A 834 PHE A 835 SITE 1 AC2 7 GLY A 696 VAL A 697 PHE A 698 SER A 699 SITE 2 AC2 7 LYS A 717 PHE A 835 HOH A1278 SITE 1 AC3 5 SER A 993 ASN A 995 GLN A 996 HOH A1202 SITE 2 AC3 5 HOH A1204 SITE 1 AC4 3 ARG A 686 ARG A 709 ARG A 755 SITE 1 AC5 4 ASN A 688 ASN A 707 ALA A 710 ASN A 711 CRYST1 85.169 75.661 68.075 90.00 92.82 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011741 0.000000 0.000578 0.00000 SCALE2 0.000000 0.013217 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014707 0.00000